Marshall Wace, LLP
- SEC CIK
- 0001318757
- Latest filing
- Aug 13, 2026
ROIV holding history
Roivant Sciences Ltd. in every 13F filed by Marshall Wace, LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ROIV overviewAll 13F holders of ROIVFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,421,478
- Value
- $50.3M
- % of portfolio
- <0.1%
- Quarters held
- 15
- Since Q3 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,421,478 | $50.3M | <0.1% | −825,465−36.7% | Reduced | Holders |
| Q1 2026 | 2,246,943 | $62.2M | 0.1% | −1,211,983−35.0% | Reduced | Holders |
| Q4 2025 | 3,458,926 | $75.1M | 0.1% | −519,075−13.0% | Reduced | Holders |
| Q3 2025 | 3,978,001 | $60.2M | 0.1% | +3,022,851+316.5% | Added | Holders |
| Q2 2025 | 955,150 | $10.8M | <0.1% | +683,327+251.4% | Added | Holders |
| Q1 2025 | 271,823 | $2.74M | <0.1% | −2,675,131−90.8% | Reduced | Holders |
| Q4 2024 | 2,946,954 | $34.9M | <0.1% | +1,505,062+104.4% | Added | Holders |
| Q3 2024 | 1,441,892 | $16.6M | <0.1% | +727,132+101.7% | Added | Holders |
| Q2 2024 | 714,760 | $7.56M | <0.1% | +660,660+1,221.2% | Added | Holders |
| Q1 2024 | 54,100 | $570.2K | <0.1% | −182,743−77.2% | Reduced | Holders |
| Q4 2023 | 236,843 | $2.66M | <0.1% | +236,843 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −1,392,906−100.0% | Sold out | Holders |
| Q2 2023 | 1,392,906 | $14.0M | <0.1% | +1,093,255+364.8% | Added | Holders |
| Q1 2023 | 299,651 | $2.21M | <0.1% | +250,670+511.8% | Added | Holders |
| Q4 2022 | 48,981 | $391.4K | <0.1% | −94,432−65.8% | Reduced | Holders |
| Q3 2022 | 143,413 | $461.0K | <0.1% | +143,413 | New | Holders |